Table 1 Demographics and clinical characteristics in each group.
Group 1 (n = 124) | Group 2 (n = 111) | Group 3 (n = 51) | P value | |
|---|---|---|---|---|
Age (years) | 60.2 ± 8.4 | 59.0 ± 9.7 | 64.4 ± 7.9 | 0.002 |
Sex (men, %) | 49 (39.5) | 49 (44.1) | 28 (54.9) | 0.176 |
T2DM duration (years) | n/a | 7.8 ± 6.0 | 8.2 ± 7.9 | 0.723 |
HbA1c (%) | n/a | 6.9 ± 0.9 | 7.1 ± 0.9 | 0.179 |
HTN duration (years) | n/a | n/a | 9.5 ± 6.1 | n/a |
Laterality (right, %) | 66 (53.2) | 57 (51.4) | 25 (49.0) | 0.875 |
BCVA (logMAR) | − 0.02 ± 0.06 | + 0.00 ± 0.06 | + 0.00 ± 0.05 | 0.035 |
Spherical equivalent (diopter) | − 0.27 ± 1.87 | − 0.28 ± 1.73 | − 0.06 ± 1.56 | 0.730 |
Intraocular pressure (mmHg) | 14.9 ± 2.8 | 15.6 ± 3.0 | 15.8 ± 2.7 | 0.103 |
Axial length (mm) | 23.6 ± 0.9 | 23.7 ± 0.8 | 23.9 ± 1.0 | 0.127 |
Central macular thickness (μm) | 252.5 ± 18.5 | 247.4 ± 17.6 | 25,373 ± 17.6 | 0.068 |
